Prof. Dr. Matthias Beckmann

Lehrstuhl für Geburtshilfe und Frauenheilkunde

Accuracy of vulvoscopic findings in detecting early vulvar neoplasia (2020) Stuebs FA, Mehlhorn G, Gaß P, Schulmeyer C, Adler W, Strehl J, Hartmann A, et al. Conference contribution Fertility Preservation: Optimization of Follicle Extraction before Cultivation in the Artificial Ovary (2020) Keckstein P, Fattahi A, Liverani L, Dittrich R, Hoffmann I, Boccaccini AR, Beckmann M, Bleisinger N Conference contribution The villoglandular Adenocarcinoma of the Cervix as a Tumor Model. A Literature Analysis (2020) Dietl A, Aumann K, Beckmann M Conference contribution Accuracy of colposcopic findings in detecting vaginal intraepithelial neoplasia: a retrospective study (2020) Stuebs FA, Adler W, Beckmann M, Gaß P, Hartmann A, Mehlhorn G, Renner SK, et al. Conference contribution Results of Stimulation Treatment through pulsatile GnRH Substitution by using an innovative, patient-controlled System (LutrePulse((R))) (2020) Hildebrandt T, Lotz L, Blum S, Fahlbusch C, Heusinger K, Cupisti S, Dittrich R, et al. Conference contribution Management of Uterus bicornis unicollis with a right-sided Outflow Obstruction in a 13-year-old Girl (2020) Lubrich H, Pontones C, Koch M, Fahlbusch C, Oppelt P, Beckmann M Conference contribution Preconceptual Counseling, Prenatal Care and peripartum Management of Female Patients with Ullrich-Turner Syndrome and a High-risk cardiovascular Profile (2020) Pontones C, Lubrich H, Schwenke E, Cupisti S, Dittrich R, Kehl S, Beckmann M, et al. Conference contribution Mammographic Density and Prognosis in Patients with primary Breast Cancer - Loss of Risk with increasing Age (2020) Heindl F, Fasching P, Hein A, Hack C, Heusinger K, Gaß P, Schulz-Wendtland R, et al. Conference contribution Influence of mindfulness-based Stress Reduction on Patients with Endometriosis in a randomized Cohort Study (2020) Antoniadis S, Burghaus S, Becker K, Beckmann M, Hack C Conference contribution Progression-free survival and overall survival in patients with advanced her2-positive breast cancer treated with trastuzumab emtansine (T-dm1) after previous treatment with pertuzumab (2020) Michel LL, Hartkopf AD, Fasching P, Kolberg HC, Hadji P, Tesch H, Häberle L, et al. Journal article